checkAd

    EQS-Adhoc  446  0 Kommentare LifeWatch AG: FDA Clearance für kontinuierlichen Vital Signs Monitoring Service - Seite 3


    materially and adversely from those anticipated or implied in the
    forward-looking statements. All forward-looking statements are based only
    on data available to LifeWatch AG at the time of the issue of this press
    release. LifeWatch AG does not undertake any obligation to update any
    forward-looking statements contained in this press release as a result of
    new information, future events or otherwise.

    THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
    SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
    GENERAL
    CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
    OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
    THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
    SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
    ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
    REGISTERED UNDER THE UNITED STATES
    SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED
    STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE
    EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
    SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
    STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM
    LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
    INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
    STATEMENTS OF THE ISSUER.

    Im Zweifelsfall gilt die englische Originalmeldung.

    Ende der Ad-hoc-Mitteilung

    +++++
    Zusatzmaterial zur Meldung:

    Dokument: http://n.eqs.com/c/fncls.ssp?u=RONJCTHPYH
    Dokumenttitel: LifeWatch(TM) erhält die FDA Clearance für ihren
    kontinuier-lichen Vital Signs Monitoring Service

    ---------------------------------------------------------------------------

    09.02.2016 Mitteilung übermittelt durch die EQS Schweiz AG. www.eqs.com -
    Medienarchiv unter http://switzerland.eqs.com/de/News
    Für den Inhalt der Mitteilung ist der Emittent verantwortlich.

    ---------------------------------------------------------------------------


    Sprache: Deutsch
    Unternehmen: LifeWatch AG
    Baarerstrasse 139
    6300 Zug
    Schweiz
    Telefon: +41 41 728 67 78
    Internet: www.lifewatch.com
    ISIN: CH0012815459
    Valorennummer: 811189
    Börsen: Freiverkehr in Berlin, Stuttgart; Open Market in
    Frankfurt ; SIX


    Ende der Mitteilung EQS Group News-Service
    ---------------------------------------------------------------------------

    435611 09.02.2016
    Seite 3 von 3




    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc LifeWatch AG: FDA Clearance für kontinuierlichen Vital Signs Monitoring Service - Seite 3 EQS Group-Ad-hoc: LifeWatch AG / Schlagwort(e): Zulassungsgenehmigung LifeWatch AG: FDA Clearance für kontinuierlichen Vital Signs Monitoring Service 09.02.2016 / 07:00 Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR. Für den Inhalt …